Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis-Reference-Cited by-同舟云学术

Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis

Published:2015-03-20 Issue:3 Volume:10 Page:e0117344
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bosco Cecilia,Crawley Danielle,Adolfsson Jan,Rudman Sarah,Van Hemelrijck Mieke

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Studies on prostate cancer: II. The effects of castration on advanced carcinoma of the prostate gland;C Huggins;Arch Surg,1941

2. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer;CJ DiBlasio;BJU Int,2008

3. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade;SB Strum;Br J Urol,1997

4. Pathologic effects of testosterone deprivation;PC Sprenkle;Curr Opin Urol,2007

5. Prostate Cancer: Principles and Practice;PJ Petrylak,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease;Southern Medical Journal;2024-05

2. Understanding Cardiovascular Risk in Prostate Cancer: Role of Disparities, Diabetes, and Aging;Current Treatment Options in Cardiovascular Medicine;2024-04-02

3. FSH Is Responsible for Androgen Deprivation Therapy–Associated Atherosclerosis in Mice by Exaggerating Endothelial Inflammation and Monocyte Adhesion;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-03

4. Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology;Cancer Innovation;2024-02-05

5. Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostate Cancer—A RADIOSA Trial Preliminary Analysis;Nutrients;2023-10-28